These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7490730)
1. N-3-substituted pyrimidinones as potent, orally active, AT1 selective angiotensin II receptor antagonists. Salimbeni A; Canevotti R; Paleari F; Poma D; Caliari S; Fici F; Cirillo R; Renzetti AR; Subissi A; Belvisi L J Med Chem; 1995 Nov; 38(24):4806-20. PubMed ID: 7490730 [TBL] [Abstract][Full Text] [Related]
2. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist. Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700 [TBL] [Abstract][Full Text] [Related]
3. The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats. Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M Eur J Pharmacol; 1995 Apr; 277(2-3):223-8. PubMed ID: 7493612 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists. Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096 [TBL] [Abstract][Full Text] [Related]
5. Molecular pharmacology of LR-B/081, a new non-peptide angiotensin AT1 receptor antagonist. Renzetti AR; Criscuoli M; Salimbeni A; Subissi A Eur J Pharmacol; 1995 Jul; 290(2):151-6. PubMed ID: 8575530 [TBL] [Abstract][Full Text] [Related]
6. Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats. Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M Eur J Pharmacol; 1996 Jul; 307(3):259-67. PubMed ID: 8836613 [TBL] [Abstract][Full Text] [Related]
7. Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996). Sircar I; Hodges JC; Quin J; Bunker AM; Winters RT; Edmunds JJ; Kostlan CR; Connolly C; Kesten SJ; Hamby JM J Med Chem; 1993 Aug; 36(16):2253-65. PubMed ID: 8360871 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists. Nicolaï E; Curé G; Goyard J; Kirchner M; Teulon JM; Versigny A; Cazes M; Caussade F; Virone-Oddos A; Cloarec A J Med Chem; 1994 Jul; 37(15):2371-86. PubMed ID: 8057285 [TBL] [Abstract][Full Text] [Related]
9. Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720). Deprez P; Guillaume J; Becker R; Corbier A; Didierlaurent S; Fortin M; Frechet D; Hamon G; Heckmann B; Heitsch H J Med Chem; 1995 Jun; 38(13):2357-77. PubMed ID: 7608902 [TBL] [Abstract][Full Text] [Related]
10. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles. Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105 [TBL] [Abstract][Full Text] [Related]
11. 4-Diazinyl- and 4-pyridinylimidazoles: potent angiotensin II antagonists. A study of their activity and computational characterization. Harmat NJ; Giorgi R; Bonaccorsi F; Cerbai G; Colombani SM; Renzetti AR; Cirillo R; Subissi A; Alagona G; Ghio C J Med Chem; 1995 Jul; 38(15):2925-37. PubMed ID: 7636853 [TBL] [Abstract][Full Text] [Related]
12. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids. Kubo K; Kohara Y; Imamiya E; Sugiura Y; Inada Y; Furukawa Y; Nishikawa K; Naka T J Med Chem; 1993 Jul; 36(15):2182-95. PubMed ID: 8340921 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249 [TBL] [Abstract][Full Text] [Related]
14. New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivatives. Bradbury RH; Allott CP; Dennis M; Girdwood JA; Kenny PW; Major JS; Oldham AA; Ratcliffe AH; Rivett JE; Roberts DA J Med Chem; 1993 Apr; 36(9):1245-54. PubMed ID: 8487261 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists. Kim TW; Yoo BW; Lee JK; Kim JH; Lee KT; Chi YH; Lee JY Bioorg Med Chem Lett; 2012 Feb; 22(4):1649-54. PubMed ID: 22264484 [TBL] [Abstract][Full Text] [Related]